Fundraising Fox
🦊/People
Sign in

Robin Mansukhani

Founder

CEO and Co-Founder at Deciduous Therapeutics

San Francisco, California, United States

FoundedDeciduous Therapeutics

Find your path to Robin

167 people in our graph share verified history with Robin — schools, employers, funds. One of them is your warm intro.

Pete KoomenunlockedRobin: together at Case Western Reserve University (2001–2004)
Robin: together at New York University
×10Robin: together at Case Western Reserve University

About

Robin Mansukhani is CEO and co-founder of Deciduous Therapeutics, a venture-backed company developing immunotherapies for age-related diseases, and previously co-founded and led Alzeca Biosciences, a CNS diagnostic imaging company. He has advised early-stage biotechs including Therini Bio and Reservoir Neurosciences, and earlier worked in venture capital at The Maple Fund and investment banking at Axiom Capital. Mansukhani co-founded BlueStamp Engineering, served a term in AmeriCorps, and holds a B.S. in Biochemistry from Case Western Reserve University.

CEO and Co-Founder at Deciduous Therapeutics

Intro paths

→

In turn, Robin can intro founders to Deciduous Therapeutics's investors below.

Deciduous Therapeutics's investors · 8

age1San Francisco · $500K – $4M checks · since 2019Axial VCSan Francisco · $100K – $5M checks · since 2019Bold Capital PartnersSanta Monica · since 2019Cornucopian Capital ManagementMontclair · since 2019CRV (Charles River Ventures)Bay Area · $250K – $5M checks · since 2019Mana VenturesEstero · since 2019Owl Capitalsince 2019quadraScope Venture FundBoston · since 2019

Co-founders at Deciduous Therapeutics

ABAnil Bhushan
Anil BhushanScientific Founder

Experience

  1. Deciduous TherapeuticsCEOcurrent2018 — presentSan Francisco Bay Area
  2. BlueStamp EngineeringCo-Founder, Board Membercurrent2011 — presentPalo Alto, San Francisco, and NYC
  3. Reservoir NeuroscienceAdvisor2019 — 2021San Francisco Bay Area
  4. Therini Bio, Inc. (formerly MedaRed, Inc.)Advisor2018San Francisco Bay Area
  5. Alzeca BiosciencesCo-Founder, CEO2011 — 2017San Francisco Bay Area
  6. Cense BiosciencesVice President, Founder2008 — 2011
  7. LivinGreen MaterialsVice President, Founder2009 — 2010
  8. New York UniversityEntrepreneur in Residence2010
  9. Axiom Capital ManagementEarly Stage Ventures2007 — 2009
  10. Azano PharmaceuticalsCo-Founder2006
  11. The Maple FundAssociate2005 — 2006

Skills & more

Venture Capital55Investments12Entrepreneurship55Private Equity16Start-ups60Business Strategy9Commercialization11Corporate Development13Emerging Markets4Medical Devices9Mergers & Acquisitions10Technology Transfer7
+6 moreBiotechnologyBusiness DevelopmentLife SciencesManagementStrategyPharmaceutical Industry

From Robin's professional profile.

Frequently asked questions

Who is Robin Mansukhani?
Robin Mansukhani is CEO and co-founder of Deciduous Therapeutics, a venture-backed company developing immunotherapies for age-related diseases, and previously co-founded and led Alzeca Biosciences, a CNS diagnostic imaging company. He has advised early-stage biotechs including Therini Bio and Reservoir Neurosciences, and earlier worked in venture capital at The Maple Fund and investment banking at Axiom Capital. Mansukhani co-founded BlueStamp Engineering, served a term in AmeriCorps, and holds a B.S. in Biochemistry from Case Western Reserve University.
Where does Robin Mansukhani work?
Robin Mansukhani is CEO and Co-Founder of Deciduous Therapeutics.
What companies did Robin Mansukhani found?
Robin Mansukhani founded Deciduous Therapeutics.
Where did Robin Mansukhani go to school?
Robin Mansukhani studied at Case Western Reserve University (B.S., Biochemistry).

Founder mafias

Same school

Shared employers